Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ministers OK new EU R&D funding program

This article was originally published in Scrip

Executive Summary

Member state ministers have given the go-ahead to the EU's new research and innovation program, Horizon 2020, which will includes funded projects in areas such as regenerative medicine, drugs for rare diseases, and clinical biomarker validation. Horizon 2020 will run for seven years from 2014, replacing the seventh framework program (FP7), which expires at the end of this year.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts